| Literature DB >> 33982178 |
Ohad Ronen1, K Thomas Robbins2, Remco de Bree3, Orlando Guntinas-Lichius4, Dana M Hartl5, Akihiro Homma6, Avi Khafif7, Luiz P Kowalski8,9, Fernando López10,11,12, Antti A Mäkitie13, Wai Tong Ng14, Alessandra Rinaldo15, Juan P Rodrigo10,11,12, Alvaro Sanabria16,17, Alfio Ferlito18.
Abstract
The inherent variability in performing specific surgical procedures for head and neck cancer remains a barrier for accurately assessing treatment outcomes, particularly in clinical trials. While non-surgical modalities for cancer therapeutics have evolved to become far more uniform, there remains the challenge to standardize surgery. The purpose of this review is to identify the barriers in achieving uniformity and to highlight efforts by surgical groups to standardize selected operations and nomenclature. While further improvements in standardization will remain a challenge, we must encourage surgical groups to focus on strategies that provide such a level.Entities:
Keywords: Head and neck cancer; Quality assurance; Standardization; Surgical oncology
Year: 2021 PMID: 33982178 DOI: 10.1007/s00405-021-06867-6
Source DB: PubMed Journal: Eur Arch Otorhinolaryngol ISSN: 0937-4477 Impact factor: 2.503